Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T13:35:17.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.6 to v3.7.0, reflecting a new version of the Study Record History page. This indicates an under-the-hood update to the page template rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-09-20T10:38:15.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision metadata in the history has been updated from v3.6.5 to v3.6.6, signaling a minor version bump in the site's revision tracking.
    Difference
    0.1%
    Check dated 2026-08-29T23:56:59.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The history now includes a new revision entry v3.6.5 and removes the previous revision v3.6.4, reflecting an update to the page's version tracking.
    Difference
    0.1%
    Check dated 2026-08-08T20:51:12.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The record history shows a new software revision, v3.6.4, replacing the previous v3.6.3. This reflects a back-end or UI update to the page history display and does not alter study data or status.
    Difference
    0.1%
    Check dated 2026-07-25T12:59:40.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    New revision entry v3.6.3 was added to the history. The previous revision v3.6.2 was removed, updating the documented version trail for the study record.
    Difference
    0.1%
    Check dated 2026-07-04T00:00:01.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.